Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HALO
#797
Halozyme Therapeutics, Inc. - Common Stock
109.4
9
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.15%
Monthly Change
+30.50%
6 month change
+58.41%
Year Change
+63.91%
Previous Close
110.7
6
Open
109.9
1
Low
109.3
5
High
111.1
5
Volume
372
Markets
US Stock Market
Healthcare
Biotechnology
HALO
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Q2, 26
Current
Key stats
Total common shares outstanding
123.22 M
116.97 M
117.6 M
118.02 M
118.61 M
113.5 M
113.5 M
Valuation ratios
Enterprise value
9.19 B
7.53 B
9 B
9.95 B
9.29 B
10.87 B
14.06 B
Price to earnings ratio
16.97
11.9
15.44
26.29
22.68
22.89
31.12
Price to sales ratio
7.57
5.64
7.46
5.97
5.28
5.77
7.84
Price to cash flow ratio
16.28
12.15
15.19
12.8
11.76
11.72
15.93
Price to book ratio
5.16
4.07
5.51
170.83
7.2
10.46
14.22
Enterprise value to EBITDA ratio
15.12
10.86
12.99
20.71
14.01
14.25
22.98
Profitability ratios
Return on assets %
0.05
0.08
0.08
-0.06
0.06
0.09
0.09
Return on equity %
0.24
0.5
0.35
-2.9
0.68
1.6
1.6
Return on invested capital %
25.27
35.13
41.65
-26.83
27.77
41.38
41.38
Gross margin %
81.73
85.77
84.41
82.56
78.97
83.54
83.54
Operating margin %
53.44
62.15
61.51
-20.56
48.98
59.8
59.8
EBITDA margin %
54.45
62.98
62.28
-19.83
50.1
60.74
60.74
Net margin %
44.59
50.71
49.46
-31.34
39.83
47.8
47.8
Liquidity ratios
Quick ratio
7.3
7.01
1.37
3.66
2.33
2.31
2.31
Current ratio
8.39
8.36
1.59
4.66
2.76
2.71
2.71
Inventory turnover
0.32
0.26
0.3
0.43
0.48
0.54
0.54
Asset turnover
0.12
0.16
0.16
0.19
0.14
0.18
0.18
Solvency ratios
Debt to assets ratio
0.69
0.73
0.36
0.85
0.72
0.83
0.83
Debt to equity ratio
3.13
4.54
1.59
43.89
8.81
14.95
14.95
Long term debt to total assets ratio
0.69
0.73
0.68
0.85
—
—
—
Long term debt to total equity ratio
3.13
4.54
3
43.89
—
—
—
Per share metrics
Operating cash flow per share
1.22
0.8
1.46
1.77
1.47
1.99
6.68
EBIT per share
1.12
1.63
1.78
-0.75
1.5
2.37
4.91
EBITDA per share
1.14
1.65
1.8
-0.72
1.54
2.41
5.03
Total debt per share
11.9
12.15
6.54
17.29
15.76
17.71
17.71
Cash per share
1.39
0.5
3.43
1.08
2.52
1.35
1.35
Net current asset value per share
9.97
9.04
10.86
6.66
8.16
7.7
7.7
Tangible book value per share
3.81
2.68
-2.14
-12.21
-10.7
-11.22
-11.22
Working capital per share
8.78
7.96
4.02
5.23
5.21
4.86
4.86
Book value per share
3.81
2.68
4.12
0.39
1.79
1.18
1.18
News
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now
AI Exhaustion? 3 Healthcare Stocks With 38% EPS Growth That Could Be the Cure
Halozyme: The Market May Be Underpricing The Second Growth Wave (NASDAQ:HALO)
Is Halozyme Therapeutics (HALO) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is BioCryst Pharmaceuticals (BCRX) Stock Outpacing Its Medical Peers This Year?
Tight Action In HALO Stock Sets Up Heavenly Gains
Are You Looking for a Top Momentum Pick? Why Halozyme Therapeutics (HALO) is a Great Choice
Zacks.com featured highlights Herbalife, Honda Motor, Marathon, Halozyme and Genworth
5 Value Stocks to Buy Right Now as Inflation Remains Sticky
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen
5 Biotech Stocks Worth Adding to Your Portfolio Now
Analysts See Drastic Change For This Particular Part Of Healthcare